share_log

RBC Capital Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $637

Benzinga ·  Apr 25 02:34  · Ratings

RBC Capital analyst Conor McNamara maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and lowers the price target from $651 to $637.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment